Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves new ocular surface anesthesia gel ➤ New drop approved to reduce IOP ➤ Newly available IOL incorporates technology that minimizes visual disturbances ➤ Interim data from Phase 1 trial for intravitreal implant to treat AMD ➤ Multiparty financing solution brought to ophthalmic practices ➤ Complimentary access to video journal ➤ ASCRS news and events
➤ Positive topline data for travoprost implant ➤ Enrollment complete for dry AMD interventional trial ➤ European Commission approves new treatment for wet AMD and DME ➤ Interim results for first-in-human trial with new glaucoma implant ➤ Three non-antibiotic drugs identified to treat ocular infection ➤ ASCRS news and events
➤ ‘Visionary Report’ sheds light on understanding, perspectives of AMD ➤ NDA submitted for Demodex blepharitis treatment ➤ Study complete for trial of oral diabetic retinopathy therapy ➤ Enrollment complete for study comparing dry eye therapeutic device to cyclosporine ➤ Gene therapy developed for ciliopathy associated with a form of Leber congenital amaurosis ➤ ASCRS news and events
➤ Autologous stem cell therapy to treat dry AMD ➤ Topline results from Phase 3 trial for GA therapy ➤ Update on Phase 3 myopia progression clinical trial ➤ FDA accepts NDA application for investigational dry eye therapy ➤ ASCRS news and events
➤ Two-year results from Phase 3 study for GA therapy ➤ BLA resubmission for bevacizumab ➤ Strategic licensing for pharmacologic treatment for keratoconus ➤ Study: Gene therapy restores some cone function to otherwise colorblind children ➤ ASCRS news and events
➤ New device for bladeless goniotomy ➤ FDA approves the first at-home digital vision test ➤ Alcon to acquire Aerie Pharmaceuticals ➤ Study: Phase 2 trial for investigational dry eye therapy meets primary endpoint ➤ ASCRS news and events
➤ Long-term safety, efficacy data reported from standalone MIGS procedure ➤ Positive clinical data in ongoing trial for investigational thyroid eye disease treatment ➤ Bioengineered cornea restores vision in 20 people ➤ ASCRS news and events
➤ FDA approves first standalone MIGS device ➤ Phase 3 clinical study results for inflammation, pain management nanosuspension ➤ Phase 2a clinical trial begins for investigational MGD treatment ➤ Registry created to collect data on canaloplasty ➤ ASCRS news and events
➤ FDA approves new multifocal IOL ➤ FDA approves new biosimilar ➤ First patient dosed in Phase 3 trial for investigational dry eye drug ➤ First patient dosed in Phase 2 trial investigating sustained delivery for wet AMD ➤ First patient dosed in Phase 2 study of small molecule to treat diabetic retinopathy ➤ Enrollment complete in Phase 3 trials evaluating myopia progression therapy ➤ Study emphasizes need for earlier glaucoma screening in black patients ➤ Company acquires diagnostic technology ➤ ASCRS news and events
➤ Small-aperture IOL receives FDA approval ➤ First patient enrolled in new LASIK trial ➤ Safety of sustained-release intravitreal implant confirmed ➤ Dosing complete in Phase 1/2a trial for injectable wet AMD therapy ➤ First patient dosed in light-activated optogenetic monotherapy study ➤ Phase 2 study for investigational new immunomodulator to treat dry eye disease ➤ Partnership created to develop tissue implant therapies ➤ ASCRS news and events